Literature DB >> 23322085

A retrospective evaluation of the effect of hydroxyquinine on RPE thickness.

Joseph Pikkel1, Otzem Chassid, Adi Sharabi-Nov, Itchak Beiran.   

Abstract

BACKGROUND: To investigate a possible structural difference in the retina of hydroxychloroquine (Plaquenil)-treated patients as an explanation for the protective effect of this medication against age-related macular degeneration (AMD).
METHODS: In this retrospective study, we compared the mean thickness of the retinal outer band (consisting of the Bruch's membrane and retinal pigment epithelium layer), as measured by optical coherence tomography (OCT), of 54 eyes of 27 hydroxychloroquine-treated rheumatoid arthritis patients (study group), 40 eyes of 20 healthy similar aged individuals (control group I), and 22 eyes of 11 non-hydroxychloroquine-treated rheumatoid arthritis patients (control group II).
RESULTS: The mean thicknesses of the outer band of the retinal pigment epithelium layer was 60.4 ± 7.4, 43.3 ± 2.7, and 39.7 ± 3.6 μm for the study group, control group I, and control group II, respectively. P values for differences in mean thicknesses were < 0.0001 between the study group and each of the control groups, and 0.086 between the two control groups.
CONCLUSION: Treatment with hydroxychloroquine was associated with increased thickness of the outer band of the retinal pigment epithelium layer. This finding may explain the protective effect of hydroxychloroquine against age-related macular degeneration (AMD).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23322085     DOI: 10.1007/s00417-012-2256-5

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  13 in total

1.  Hydroxychloroquine retinopathy.

Authors:  J T Coyle
Journal:  Ophthalmology       Date:  2001-02       Impact factor: 12.079

2.  THE PATHOLOGY OF CHLOROQUINE RETINOPATHY.

Authors:  H N BERNSTEIN; J GINSBERG
Journal:  Arch Ophthalmol       Date:  1964-02

3.  Retinopathy following chloroquine therapy.

Authors:  H E HOBBS; A SORSBY; A FREEDMAN
Journal:  Lancet       Date:  1959-10-03       Impact factor: 79.321

4.  Unusual ocular lesions in a case of systemic lupus erythematosus.

Authors:  A CAMBIAGGI
Journal:  AMA Arch Ophthalmol       Date:  1957-03

5.  High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy.

Authors:  Julio A Rodriguez-Padilla; Thomas R Hedges; Bryan Monson; Vivek Srinivasan; Maciej Wojtkowski; Elias Reichel; Jay S Duker; Joel S Schuman; James G Fujimoto
Journal:  Arch Ophthalmol       Date:  2007-06

6.  Chloroquine toxicity in the human eye. Histopathologic observations by electron microscopy.

Authors:  M S Ramsey; B S Fine
Journal:  Am J Ophthalmol       Date:  1972-02       Impact factor: 5.258

7.  Sparing of age-related macular degeneration in rheumatoid arthritis.

Authors:  Patrick L McGeer; John Sibley
Journal:  Neurobiol Aging       Date:  2005-04-19       Impact factor: 4.673

8.  Prevalence of age-related macular degeneration in the United States.

Authors:  David S Friedman; Benita J O'Colmain; Beatriz Muñoz; Sandra C Tomany; Cathy McCarty; Paulus T V M de Jong; Barbara Nemesure; Paul Mitchell; John Kempen
Journal:  Arch Ophthalmol       Date:  2004-04

Review 9.  A role for local inflammation in the formation of drusen in the aging eye.

Authors:  Don H Anderson; Robert F Mullins; Gregory S Hageman; Lincoln V Johnson
Journal:  Am J Ophthalmol       Date:  2002-09       Impact factor: 5.258

10.  Ocular toxicity of antimalarials in dermatology: a survey of current practice.

Authors:  N H Cox; W D Paterson
Journal:  Br J Dermatol       Date:  1994-12       Impact factor: 9.302

View more
  2 in total

1.  Cyclodextrin-mediated gold nanoparticles as multisensing probe for the selective detection of hydroxychloroquine drug.

Authors:  Jaise Mariya George; Beena Mathew
Journal:  Korean J Chem Eng       Date:  2021-03-05       Impact factor: 3.309

2.  Effect of Hydroxychloroquine on the Retinal Layers: A Quantitative Evaluation with Spectral-Domain Optical Coherence Tomography.

Authors:  Hasim Uslu; Bulent Gurler; Aydin Yildirim; Mehmet Gurkan Tatar; Feride Aylin Kantarcı; Hasan Goker; Hatice Seval Pehlevan; Hatice Nur Colak
Journal:  J Ophthalmol       Date:  2016-08-30       Impact factor: 1.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.